Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Codeine/dipyrone - Eurofarma

Next Previous
Drug Profile

Codeine/dipyrone - Eurofarma

Alternative Names: Codeine 30 mg/dipyrone 500 mg; Dipyrone/codeine; Dipyrone/codeine - Eurofarma

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eurofarma
  • Class Analgesics; Antiplatelets; Antipyretics; Antitussives; Morphinans; Nonsteroidal anti-inflammatories; Opioid analgesics; Pyrazolones; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Postoperative pain

Most Recent Events

  • 30 May 2024 Eurofarma completes the phase III CODI trial in Postoperative pain (PO, Tablet) in Brazil (NCT04972292)
  • 08 Nov 2023 Phase-III clinical trials in Postoperative pain in Brazil (PO) (NCT04972292)
  • 22 Jul 2021 Eurofarma plans a phase III trial in Postoperative pain (PO, Tablet) in July 2022 (NCT04972292)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top